Different effects of lysophosphatidic acid on L-type calcium current in neonatal rat ventricular myocytes with and without H2O2 treatment

Prostaglandins and Other Lipid Mediators

Volumn 118-119, Issue , 2015, Pages 1-10

  Sun, Renren ^a   Zhang, Duoduo ^a   Zhang, Jun ^a   Feng, Qiuyan ^a   Zhang, Yan ^a   Zhao, Chunyan ^a   Zhang, Wenjie ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Cav1.2; Calcineurin; H2O2; L type calcium current; Lysophosphatidic acid; NFAT

Indexed keywords

CALCINEURIN; CALCIUM CHANNEL L TYPE; HYDROGEN PEROXIDE; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; L-TYPE CALCIUM CHANNEL ALPHA(1C); LYSOPHOSPHOLIPID;

ACTION POTENTIAL DURATION; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GENE EXPRESSION; GENE TRANSLOCATION; HEART MUSCLE CELL; HEART VENTRICLE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; MUSCLE CELL; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; WISTAR RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELLS, CULTURED; GENE EXPRESSION; HEART VENTRICLES; HYDROGEN PEROXIDE; LYSOPHOSPHOLIPIDS; MUSCLE CELLS; NFATC TRANSCRIPTION FACTORS; PATCH-CLAMP TECHNIQUES; RATS, WISTAR;

EID: 84926658484     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2015.03.008     Document Type: Article

References (55)

1. R. Ashrafi, H. Hussain, R. Brisk, L. Boardman, and C. Weston Clinical disease registries in acute myocardial infarction World J Cardiol 6 2014 415 423
2. X. Feng, J. Li, and J. Liu Protective effect of FK506 on myocardial ischemia/reperfusion injury by suppression of CaN and ASK1 signaling circuitry Cardiovasc Toxicol 11 2011 18 27
3. M.A. Talukder, J.L. Zweier, and M. Periasamy Targeting calcium transport in ischaemic heart disease Cardiovasc Res 84 2009 345 352
4. + exchanger in rat ventricular myocytes Drug Des Devel Ther 8 2014 1257 1267
5. N. Gorenkova, E. Robinson, D.J. Grieve, and A. Galkin Conformational change of mitochondrial complex I increases ROS sensitivity during ischemia Antioxid Redox Signal 19 2013 1459 1468
6. D. Garcia-Dorado, M. Ruiz-Meana, J. Inserte, A. Rodriguez-Sinovas, and H.M. Piper Calcium-mediated cell death during myocardial reperfusion Cardiovasc Res 94 2012 168 180
7. 2-induced apoptosis via down-regulation of reactive oxygen species in cardiac myocytes Mol Cell Biochem 347 2011 21 28
8. 2 Am J Physiol Heart Circ Physiol 291 2006 H854 H860
9. J. Aoki, A. Inoue, and S. Okudaira Two pathways for lysophosphatidic acid production Biochim Biophys Acta 1781 2008 513 518
10. N. Aaltonen, J.T. Laitinen, and M. Lehtonen Quantification of lysophosphatidic acids in rat brain tissue by liquid chromatography-electrospray tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 878 2010 1145 1152
11. H. Cai, and Y. Xu The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells Cell Commun Signal 11 2013 31 44
12. Y.J. Xu, S.S. Rathi, D.C. Chapman, A.S. Arneja, and N.S. Dhalla Mechanisms of Lysophosphatidic acid-induced DNA synthesis in vascular smooth muscle cells J Cardiovasc Pharmacol 41 2003 381 387
13. I. Wocławek-Potocka, P. Rawinska, and I. Kowalczyk-Zieba Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tract Mediators Inflamm 2014 2014 649702
14. Y. Kihara, M. Maceyka, S. Spiegel, and J. Chun Lysophospholipid receptor nomenclature review: IUPHAR Review 8 Br J Pharmacol 171 2014 3575 3594
15. D. Meyer zu Heringdorf, and K.H. Jakobs Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism Biochim Biophys Acta 1768 2007 923 940
16. R. Hilal-Dandan, C.K. Means, and A.B. Gustafsson Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho J Mol Cell Cardiol 36 2004 481 493
17. J.S. Beltramea, M.S. Sordellia, M. Cellab, S. Perez Martinezc, A.M. Franchib, and M.L. Ribeirol Lysophosphatidic acid increases the production of pivotal mediators of decidualization and vascularization in the rat uterus Placenta 34 2013 751 756
18. J. Aoki, A. Taira, and Y. Takanezawa Serum lysophosphatidic acid is produced through diverse phospholipase pathways J Biol Chem 277 2002 48737 48744
19. Z.G. Li, Z.C. Yu, and Y.P. Yu Lysophosphatidic acid level and the incidence of silent brain infarction in patients with nonvalvular atrial fibrillation Int J Mol Sci 11 2010 3988 3998
20. T. Dohi, K. Miyauchi, and R. Ohkawa Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome Atherosclerosis 229 2013 192 197
21. S.S. Smyth, P. Mueller, F. Yang, J.A. Brandon, and A.J. Morris Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis Arterioscler Thromb Vasc Biol 34 2014 479 486
22. W. Siess, K.J. Zangl, and M. Essler Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions Proc Natl Acad Sci U S A 96 1999 6931 6936
23. X. Chen, X.Y. Yang, and N.D. Wang Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction Scand J Clin Lab Invest 63 2003 497 503
24. J. Chen, Y. Han, and W. Zhu Specific receptor subtype mediation of LPA-induced dual effects in cardiac fibroblasts FEBS Lett 580 2006 4737 4745
25. J. Chen, Y. Chen, and W. Zhu Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFκB signal pathways J Cell Biochem 103 2008 1718 1731
26. X.X. Zhang, C.O. Zhao, and J. Lu Proarrhythmia effect of lysophosphatidic acid on isolated working rat heart (Chinese) Zhongguo Ying Yong Sheng Li Xue Za Zhi 24 5 2008 70
27. Y. Wei, L.Q. Zhao, and B.Z. Qi Lysophosphatidic acid increases the electrophysiological instability of adult rabbit ventricular myocardium by augmenting L-type calcium current PLoS ONE 7 2012 e45862
28. T. Chin-Feng, U. Kwo-Chang, W. Der-Jinn, T. Tsung-Po, and L. Chung-Sheng Remodeled left ventricular myocardium remote to infarction sites is the arrhythmogenic substrate for sudden cardiac death Med Hypotheses 75 2010 368 371
29. H. Ashikaga, S.R. Mickelsen, and D.B. Ennis Electromechanical analysis of infarct border zone in chronic myocardial infarction Am J Physiol Heart Circ Physiol 289 2005 H1099 H1105
30. S. Kettlewell, F.L. Burton, G.L. Smith, and A.J. Workman Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation Cardiovasc Res 99 2013 215 224
31. 2+ current downregulation in rat atrial myocytes during heart failure Circ Res 89 2001 607 613
32. 2+ current in rat ventricular myocytes J Mol Cell Cardiol 30 1998 1955 1965
33. M.F. Bierhuizen, M. Boulaksil, and L. van Stuijvenberg In calcineurin-induced cardiac hypertrophy expression of Nav1.5, Cx40 and Cx43 is reduced by different mechanisms J Mol Cell Cardiol 45 2008 373 384
34. 2+ channel activity induces hypertrophy and heart failure in mice J Clin Invest 122 2012 280 290
35. O. Murch, M. Collin, and C. Thiemermann Lysophosphatidic acid reduces the organ injury caused by endotoxemia - a role for G-protein-coupled receptors and peroxisome proliferator-activated receptor-gamma Shoc 27 2007 48 54
36. R.P. Oude Elferink, R. Bolier, and U.H. Beuers Lysophosphatidic acid and signaling in sensory neurons Biochim Biophys Acta 1851 2015 61 65
37. G. Tigyi, and A.L. Parrill Molecular mechanisms of lysophosphatidic acid action Prog Lipid Res 42 2003 498 526
38. C. Pages, M.F. Simon, P. Valet, and J.S. Saulnier-Blache Lysophosphatidic acid synthesis and release Prostaglandins Other Lipid Mediat 64 2001 1 10
39. Y. Liu, Y. Zhang, and K. Lin Protective effect of piperine on electrophysiology abnormalities of left atrial myocytes induced by hydrogen peroxide in rabbits Life Sci 94 2014 99 105
40. vβ subunit interaction Biophys J 101 2011 2661 2670
41. I.Q. Fan, B. Chen, and J.D. Marsh Transcriptional regulation of L-type calcium channel expression in cardiac myocytes J Mol Cell Cardiol 32 2000 1841 1849
42. v1.2 mRNA Am J Physiol Heart Circ Physiol 292 2007 H622 H631
43. P. Zhang, A.S. Lader, M.A. Etcheverry, and H.F. Cantiello Crotoxin potentiates L-type calcium currents and modulates the action potential of neonatal rat cardiomyocytes Toxicon 55 2010 1236 1243
44. 2+ channels and transient receptor potential channels activates pathological hypertrophy signaling J Mol Cell Cardiol 53 2012 657 667
45. A.M. Gillis, K.M. Kavanagh, H.J. Mathison, J.R. Somers, S. Zhan, and H.J. Duff Heart block in mice overexpressing calcineurin but not NF-AT3 Cardiovasc Res 64 2004 488 495
46. J.D. Molkentin Parsing good versus bad signaling pathways in the heart: role of calcineurin-nuclear factor of activated T-cells Circ Res 113 2013 16 19
47. J.D. Molkentin Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs Cardiovasc Res 63 2004 467 475
48. J. Guo, S. Mi, J. Li, W. Liu, Y. Yin, and Q. Wei Calcineurin B subunit acts as a potential agent for preventing cardiac ischemia/reperfusion injury Mol Cell Biochem 370 2012 163 171
49. J.M. Berry, V. Le, and D. Rotter Reversibility of adverse, calcineurin-dependent cardiac remodeling Circ Res 109 2011 407 417
50. 2+-calcineurin-NFAT signaling pathway Biochem Biophys Res Commun 407 2011 807 812
51. 2-induced oxidative stress in rat cardiac H9C2 cells Phytother Res 24 2010 404 409
52. X.Y. Qi, Y.H. Yeh, and L. Xiao Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current Circ Res 103 2008 845 854
53. 2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway J Mol Cell Cardiol 33 2001 249 259
54. 2+ channel Circ Res 105 2009 51 60
55. Na is in the common final pathway to heart block in murine hearts overexpressing calcineurin Am J Physiol Heart Circ Physiol 291 2006 H2669 H2679